In mice, prophylactic administration of TNF inhibitors mitigates some of the immune-related adverse effects of immune checkpoint blockade treatment, and also improves to some extent the anti-tumour effect of this immunotherapy.
- Elisabeth Perez-Ruiz
- Luna Minute
- Ignacio Melero